Skip to main content
Premium Trial:

Request an Annual Quote

Incyte, Glaxo Wellcome Ink Genomic Database Partnership Deal

Premium

PALO ALTO, Calif.--Incyte Pharmaceuticals has signed a multiyear genomic database partnership that will provide Glaxo Wellcome with access to specific LifeSeq database products in exchange for annual access fees, and could yield royalty payments to Incyte from sales of products developed with Incyte's products and database information.

The deal gives Glaxo Wellcome access to the database at eight research sites, including Research Triangle Park, N.C.; the Geneva Biomedical Research Institute; the Glaxo Wellcome Medicines Research Center in Stevenage, U.K.; and Affymax Research Institute here.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.